Perlmutter Cancer Center 160 E 34th St

New York, New York 10016-4744

1 studies enrolling now · 1 studies all time

What they study most

Metastatic HER2-positive Breast Cancer

Studies at this site

• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now